Susquehanna International Group’s Cocrystal Pharma COCP Stock Holding History
Bought
Maintained
Sold
Other funds holding COCP
PA
Susquehanna International Group's COCP Position: Q3 2025 in Review
Susquehanna International Group sold out of Cocrystal Pharma (COCP) in Q3 2025, closing a stake of 40,619 shares — an estimated $60.5K sold.
Susquehanna International Group first reported a position in COCP in Q3 2018 and held it in 12 quarters. The position peaked at $135K in Q3 2023. 22 funds tracked by Wall St. Rank hold COCP as of Q3 2025.
- Susquehanna International Group reported no remaining Cocrystal Pharma position as of Q3 2025 after selling out during the quarter.
- Susquehanna International Group sold 40,619 Cocrystal Pharma shares in Q3 2025, an estimated $60.5K.
- Susquehanna International Group first reported a position in Cocrystal Pharma in Q3 2018 and held it in 12 quarters.
- Susquehanna International Group's Cocrystal Pharma position peaked at $135K in Q3 2023.
- 22 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2025.
Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.